Protocol Overview
This 20mg blend contains BPC-157 (10mg) + TB-500 (10mg) in a single vial. BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from a protein found in gastric juice, extensively studied for tissue repair, gut healing, and anti-inflammatory effects. TB-500 is a synthetic fragment of Thymosin Beta-4, studied for its roles in cell migration, wound healing, and cardiovascular protection.
Combining these two peptides in a blend is popular in research settings because they act through complementary mechanisms — BPC-157 primarily through NO/VEGF pathways and the enteric nervous system, while TB-500 primarily through actin regulation and cell motility pathways. Together they may offer broader tissue-support coverage than either alone.
Reconstitution
Recommended BAC water: 2 mL. Resulting concentration: 20 mg ÷ 2 mL = 10 mg/mL total (5 mg/mL each peptide).
Dosing Schedule
| Dose | Frequency | Volume (2mL reconstitution) | U-100 Units |
|---|---|---|---|
| 250 mcg each / 500 mcg total | Daily | 0.05 mL | 5 units |
| 500 mcg each / 1 mg total | Daily | 0.10 mL | 10 units |
| 1 mg each / 2 mg total | Daily or EOD | 0.20 mL | 20 units |
Typical research cycle: 4–12 weeks, subcutaneous injection. Inject into the lower abdomen or outer thigh.
Supplies
- BPC-157 + TB-500 20mg blend vial
- Bacteriostatic water (BAC water), 10 mL vial
- U-100 insulin syringes, 0.5 mL or 1 mL, 30G × ½ inch
- Alcohol swabs
- Sharps container